Persistence of immunity and impact of a third (booster) dose of an inactivated SARS-CoV-2 vaccine, BBV152; a phase 2, double-blind, randomised controlled trial
bioRxiv (2022) - Comments
doi: 10.1101/2022.01.05.22268777 

Krishna Mohan Vadrevu, Brunda Ganneru, Siddharth Reddy, Harsh Jogdand, Dugyala Raju, Usha Praturi, Gajanan Sapkal, Pragya Yadav, Prabhakar Reddy, Savita Verma, Chandramani Singh, Sagar Vivek Redkar, Chandra Sekhar Gillurkar, Jitendra Singh Kushwaha, Satyajit Mohapatra, Amit Bhate, Sanjay Rai, Raches Ella, Priya Abraham, Sai Prasad